Document Preview Unavailable
Dipeptidyl peptidase‐4 inhibitor, anagliptin, alters hepatic insulin clearance in relation to the glycemic status in Japanese individuals with type 2 diabetes
Abe, Takahiro; Matsubayashi, Yasuhiro; Muragishi, Sayaka; Yoshida, Akihiro; Suganami, Hideki; et al. Journal of Diabetes Investigation Vol. 12, Iss. 10, (Oct 2021): 1805-1815.You might have access to this document
-
Try and log in through your institution to see if they have access to the full text.
Log in through your library